PlexusDx's Precision Peptide Genetic Test identifies key variants including GLP1R rs6923761 and GIPR rs1800437 that influence GLP-1 pathway sensitivity and medication response
While GLP1 receptor agonists have long been recognized for their glucose-lowering and weight-loss effects, they now offer potential for improving liver outcomes, especially in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD) or its more advanced form, metabolic dysfunction-associated steatohepatitis (MASH)
The analyses of lipid profiles, DBP, HbA1c, and FBG showed no remarkable changes [27]
In women with PCOS, it reduces facial and body hair (hirsutism), clears androgen-driven acne, and slows scalp thinning
For women with a history of anorexia, bulimia, or restrictive eating, this appetite suppression can trigger disordered patterns
People arent always ready for how thats going to feel, Borelli says